Overview
Aidoc is a clinical AI company founded in 2016 in Tel Aviv by CEO Elad Walach and co-founders. It builds AI that analyzes medical imaging in real time to flag urgent and life-threatening findings, helping radiologists and care teams prioritize cases and reduce preventable diagnostic errors. Aidoc's technology is deployed across nearly 2,000 hospitals and analyzes tens of millions of patient cases each year.
Technology
Aidoc has evolved from individual FDA-cleared detection algorithms to CARE, a clinical foundation model spanning multiple conditions and imaging modalities. The company reports a landmark FDA clearance for a comprehensive foundation-model-based triage system. Its platform integrates into existing hospital imaging and workflow systems, surfacing prioritized findings and coordinating care across departments.
Funding and Scale
Aidoc raised a $150M Series E led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Vision Fund 2, and NVIDIA's NVentures, bringing total funding above $500M. With broad hospital deployment, deep funding, and a healthcare foundation model strategy, Aidoc is among the most established clinical AI imaging companies.